SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-146013
Filing Date
2019-05-14
Accepted
2019-05-14 08:10:07
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d645945d10q.htm 10-Q 879055
2 EX-10.1 d645945dex101.htm EX-10.1 82584
3 EX-31.1 d645945dex311.htm EX-31.1 10188
4 EX-31.2 d645945dex312.htm EX-31.2 10402
5 EX-32.1 d645945dex321.htm EX-32.1 4307
6 EX-32.2 d645945dex322.htm EX-32.2 4243
  Complete submission text file 0001193125-19-146013.txt   4481249

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mgtx-20190331.xml EX-101.INS 704554
8 XBRL TAXONOMY EXTENSION SCHEMA mgtx-20190331.xsd EX-101.SCH 52913
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgtx-20190331_cal.xml EX-101.CAL 64711
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgtx-20190331_def.xml EX-101.DEF 181583
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgtx-20190331_lab.xml EX-101.LAB 426327
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgtx-20190331_pre.xml EX-101.PRE 313958
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38520 | Film No.: 19820513
SIC: 2836 Biological Products, (No Diagnostic Substances)